Related Experiment Video
Updated: May 16, 2026
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
Medulloblastoma biology in the post-genomic era
Tenley C Archer1, Scott L Pomeroy
1Department of Neurology, Children's Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Fegan 1103, Boston, MA 02115, USA.
Abstract:
Medulloblastomas, the most common malignant pediatric brain tumors, are comprised of four molecularly distinct subtypes. However, treatment has yet to exploit these molecular vulnerabilities. Three recent studies sequenced a total of 310 primary tumors and identified that two of the four medulloblastoma subtypes are concomitantly associated with subtype-specific mutations as previously characterized. In contrast, the overwhelming majority of mutations occurred only once in the entire cohort and just 12 genes were recurrently mutated with statistical significance. Perturbations in epigenetic regulation are emerging as a unifying theme in cancer and similarly recurring mutations in epigenetic mechanisms were distributed across all subtypes in medulloblastoma. Designing targeted therapies to such a molecularly diverse disease in the post-genomic era presents new challenges. This will require novel methods to link these nonrecurrent mutations into pathways, and preclinical models that faithfully recapitulate patient driver events. Presently, medulloblastoma reinforces epigenetic mechanisms as a tantalizing therapeutic target in cancers.
Insights
Pediatric brain tumors called medulloblastomas have distinct molecular subtypes. While some subtype-specific mutations exist, epigenetic alterations are common across all types, offering potential therapeutic targets.
Area of Science:
- Neuro-oncology
- Genomics
- Epigenetics
Background:
- Medulloblastomas are the most common malignant pediatric brain tumors.
- These tumors consist of four distinct molecular subtypes.
- Current treatments do not fully exploit the molecular vulnerabilities of these subtypes.
Purpose of the Study:
- To analyze the mutational landscape of medulloblastomas across molecular subtypes.
- To identify recurring mutations and their association with specific subtypes.
- To explore the role of epigenetic alterations in medulloblastoma development and as potential therapeutic targets.
Main Methods:
- Analysis of genomic data from 310 primary medulloblastoma tumors.
- Identification and characterization of recurrently mutated genes.
- Assessment of mutations in epigenetic regulatory mechanisms across subtypes.
Main Results:
- Two medulloblastoma subtypes showed associations with previously characterized subtype-specific mutations.
- The majority of mutations were rare, with only 12 genes found to be recurrently mutated.
- Recurring mutations in epigenetic mechanisms were observed across all medulloblastoma subtypes.
Conclusions:
- Medulloblastomas exhibit significant molecular diversity, with both subtype-specific and broadly distributed mutations.
- Epigenetic dysregulation is a common feature across medulloblastoma subtypes, presenting a potential therapeutic avenue.
- Targeted therapy development requires novel methods to link non-recurrent mutations into pathways and improved preclinical models.
More Related Videos
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:02Genomics
02:55The Nucleolus